Ceredex Value Advisors LLC Lowers Position in Ventas, Inc. $VTR

Ceredex Value Advisors LLC trimmed its stake in shares of Ventas, Inc. (NYSE:VTR) by 21.5% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 358,500 shares of the real estate investment trust’s stock after selling 98,450 shares during the period. Ceredex Value Advisors LLC’s holdings in Ventas were worth $25,091,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of Ventas by 97.7% in the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after purchasing an additional 18,146 shares during the last quarter. Investment Management Corp of Ontario lifted its position in shares of Ventas by 1,019.0% in the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock worth $8,403,000 after buying an additional 121,170 shares in the last quarter. Hudson Bay Capital Management LP bought a new position in Ventas during the second quarter valued at approximately $17,568,000. SCS Capital Management LLC bought a new position in Ventas during the second quarter valued at approximately $13,788,000. Finally, Y Intercept Hong Kong Ltd grew its holdings in Ventas by 28.5% during the 3rd quarter. Y Intercept Hong Kong Ltd now owns 83,524 shares of the real estate investment trust’s stock valued at $5,846,000 after buying an additional 18,527 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the transaction, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. The trade was a 32.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. This trade represents a 0.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 86,106 shares of company stock valued at $6,931,397. Insiders own 1.00% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. KeyCorp lifted their price objective on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 target price on shares of Ventas in a research report on Monday, February 9th. Royal Bank Of Canada raised their target price on shares of Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a report on Tuesday, February 10th. Jefferies Financial Group restated a “buy” rating and issued a $93.00 price target on shares of Ventas in a research report on Monday, December 15th. Finally, UBS Group reiterated a “neutral” rating and set a $85.00 price objective on shares of Ventas in a research report on Monday, February 9th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $89.00.

Ventas Stock Performance

Shares of NYSE:VTR opened at $86.22 on Tuesday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 12 month low of $60.15 and a 12 month high of $87.87. The company has a market capitalization of $40.95 billion, a price-to-earnings ratio of 159.66, a PEG ratio of 2.07 and a beta of 0.73. The firm’s 50-day moving average is $80.79 and its 200 day moving average is $75.93.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the previous year, the business earned $0.81 EPS. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Research analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.